Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 3, 2026ReceptorsOpen Access

Differential Regulation of Soluble and Membrane 4-1BB and OX-40 Within the Peripheral Compartment of Cervical Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

JRJosé Manuel Rojas‐DíazFGFernando Galvan-LedezmaKKKsenia Klimov‐Kravtchenko

Discussion

Loading...

Member takes

Overview

Observational case-control study reveals differential regulation of soluble and membrane 4-1BB and OX-40 in cervical cancer, suggesting distinct immune checkpoint dynamics across tumor stages.

Key Points

  • To evaluate and compare the peripheral expression of soluble and membrane-bound isoforms of 4-1BB and OX-40 between cervical cancer patients and healthy controls across disease stages.
  • Quantified plasma concentrations of soluble 4-1BB (s4-1BB) and soluble OX-40 (sOX-40) using ELISA in 20 treatment-naïve cervical cancer patients and 20 healthy controls.
  • Assessed membrane expression of 4-1BB and OX-40 on circulating T cells and natural killer cells via flow cytometry, followed by correlation and disease stage-stratified evaluations.
  • Plasma concentrations of soluble 4-1BB and soluble OX-40 were significantly higher in cervical cancer patients compared with healthy controls.
  • Membrane 4-1BB was upregulated on both peripheral T cells and natural killer cells, whereas membrane OX-40 was selectively elevated only on natural killer cells.
  • Soluble 4-1BB showed a moderate positive correlation with T-cell membrane 4-1BB; membrane 4-1BB decreased in advanced-stage disease, while soluble concentrations remained unchanged.

Cite This Study

Rojas‐Díaz et al. (2026) studied this question.

synapsesocial.com/papers/6a993653636c6408cfa7f6aehttps://doi.org/10.3390/receptors5030028
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Soluble levels of 4‐1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma2024
  2. 2Uncovering the Expression Pattern of the Costimulatory Receptors ICOS, 4-1BB, and OX-40 in Exhausted Peripheral and Tumor-Infiltrating Natural Killer Cells from Patients with Cervical Cancer2024 · 8 citations
  3. 3Integrated Analysis of OX40/OX40L Genetic Variants and Circulating Soluble Immune Checkpoint Markers in Laryngeal Cancer Recurrence2026
  4. 4OX40 signaling in cancer immunotherapy: mechanisms of action, translational applications, and therapeutic perspectives2026 · 2 citations
  5. 5FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells2020 · 23 citations